ArticleOncoTargets and therapy2019

Long-term progression-free survival of apatinib monotherapy for relapsed ovarian cancer: a case report and literature review.

Di Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.